Therapeutic Management and Outcome of Locoregional Recurrence After Curative Colorectal Cancer Therapy—a Single-Center Analysis

Journal of Gastrointestinal Surgery

Volumn 18, Issue 11, 2014, Pages 2026-2033

  Kogler, Pamela ^a   Kafka Ritsch, Reinhold ^a   Sieb, Michael ^b   Sztankay, Arpad ^a   Pratschke, Johann ^a   Zitt, Matthias ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b TiRoLab   (Austria)

Author keywords

Colorectal cancer; Locoregional recurrence; Outcome

Indexed keywords

ADULT; AGED; AUSTRIA; CHEMORADIOTHERAPY; COHORT ANALYSIS; COLON RESECTION; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; FACTUAL DATABASE; FEMALE; HUMAN; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; NEOPLASM RECURRENCE, LOCAL; PALLIATIVE THERAPY; PATHOLOGY; PROCEDURES; PROGNOSIS; RECTAL NEOPLASMS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AUSTRIA; CHEMORADIOTHERAPY; COHORT STUDIES; COLECTOMY; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PALLIATIVE CARE; PROGNOSIS; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 84920873898     PISSN: 1091255X     EISSN: 18734626     Source Type: Journal    
DOI: 10.1007/s11605-014-2633-y     Document Type: Article

References (32)

1. Boyle P, Levin B. World Cancer Report 2008. WHO press, Geneva
2. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr, accessed on day/month/year.
3. Levin B, Lieberman DA, McFarland B, Smith RA, Brooks D, Andrews KS Dash C, Giardiello FM, Glick S, Levin TR, Pickhardt P, Rex DK, Thorson A, Winawer SJ. Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008;58:130–160.
4. Bosetti C, Levi F, Rosato V, Bertuccio P, Lucchini F, Negri E, La Vecchia C. Recent trends in colorectal cancer mortality in Europe. Int. J. Cancer 2011; 129:180–191.
5. Larkin JO, O’Connell PR. Multivisceral Resection for T4 or Recurrent Colorectal Cancer. Dig Dis 2012;30(suppl 2):96–101.
6. Manfredi S, Bouvier AM, Lepage C, Hatem C, Dancourt V, Faivre J. Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population. British Journal of Surgery 2006; 93: 1115–1122.
7. Lehnert T, Methner M, Pollok A, Schaible A, Hinz U, Herfarth C. Multivisceral Resection for Locally Advanced Primary Colon and Rectal Cancer. An Analysis of Prognostic Factors in 201 Patients. Annals of Surgery 2002; Vol. 235, No. 2, 217–225.
8. Seo SI, Lim SB, Yoon YS, Kim CW, Yu CS, Kim TW, Kim JH, Kim JC. Comparison of Recurrence Patterns Between ≤ 5 Years and >5 Years After Curative Operations in Colorectal Cancer Patients. Journal of Surgical Oncology 2013;108:9–13.
9. Bowne WB, Lee B, Wong WD, Ben-Porat L, Shia J, Cohen AM, Enker WE, Guillem JG, Paty PB, Weiser MR. Operative Salvage for Locoregional Recurrent Colon Cancer After Curative Resection: An Analysis of 100 Cases. Dis Colon Rectum 2005; 48: 897–909.
10. Kraemer M, Wiratkapun S, Seow-Choen F, Ho YH, Eu KW, Nyam D. Stratifying Risk Factors for Follow-Up: A Comparison of Recurrent and Nonrecurrent Colorectal Cancer. Dis Colon Rectum 2001;44:815–821.
11. Heald RJ. The ‘Holy Plane’ of rectal surgery. J R Soc Med. 1988,Sep;81(9):503–8.
12. Wiig JN, Carlsen E, Søreide O. Mesorectal excision for rectal cancer: a view from Europe. Semin Surg Oncol 1998; Sep;15(2):78–86.
13. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med. 1997; Apr 3;336(14):980–7.
14. Kapiteijn E, Kranenbarg EK, Steup WH, Taat CW, Rutten HJ, Wiggers T, van Krieken JH, Hermans J, Leer JW, van de Velde CJ. Total mesorectal excision (TME) with or without preoperative radiotherapy in the treatment of primary rectal cancer. Prospective randomised trial with standard operative and histopathological techniques. Dutch ColoRectal Cancer Group. Eur J Surg. 1999; May;165(5):410–20.
15. Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R; German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004; Oct 21;351(17):1731–40.
16. Rödel C, Liersch T, Becker H, Fietkau R, Hohenberger W, Hothorn T, Graeven U, Arnold D, Lang-Welzenbach M, Raab HR, Sülberg H, Wittekind C, Potapov S, Staib L, Hess C, Weigang-Köhler K, Grabenbauer GG, Hoffmanns H, Lindemann F, Schlenska-Lange A, Folprecht G, Sauer R; German Rectal Cancer Study Group. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial. Lancet Oncol. 2012; Jul;13(7):679–87.
17. Fleming FJ, Påhlman L, Monson JR. Neoadjuvant therapy in rectal cancer. Dis Colon Rectum 2011; Jul;54(7):901–12.
18. Zitt M, Mühlmann G, Weiss H, Kafka-Ritsch R, Oberwalder M, Kirchmayr W, Margreiter R, Ofner D, Klaus A. Assessment of risk-independent follow-up to detect asymptomatic recurrence after curative resection of colorectal cancer. Langenbecks Arch Surg. 2006; Aug;391(4):369–75.
19. Kneschaurek P, Wehrmann R, Hugo C, Stepan R, Lukas P, Molls M. The flab method of intraoperative radiotherapy. Strahlenther Onkol. 1995; Feb;171(2):61–9.
20. Chang KH, Smith MJ, McAnena OJ, Aprjanto AS, Dowdall JF. Increased use of multidisciplinary treatment modalities adds little to the outcome of rectal cancer treated by optimal total mesorectal excision. Int J Colorectal Dis. 2012; Oct;27(10):1275–83.
21. den Dulk M, Krijnen P, Marijnen CA, Rutten HJ, van de Poll-Franse LV, Putter H, Meershoek-Klein Kranenbarg E, Jansen-Landheer ML, Coebergh JW, van de Velde CJ. Improved overall survival for patients with rectal cancer since 1990: the effects of TME surgery and pre-operative radiotherapy. Eur J Cancer. 2008; Aug;44(12):1710–6.
22. Kusters M, Marijnen CA, van de Velde CJ, Rutten HJ, Lahaye MJ, Kim JH, Beets-Tan RG, Beets GL. Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol. 2010; May;36(5):470–6.
23. Sauer R, Liersch T, Merkel S, Fietkau R, Hohenberger W, Hess C, Becker H, Raab HR, Villanueva MT, Witzigmann H, Wittekind C, Beissbarth T, Rödel C. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol. 2012; Jun 1;30(16):1926–33.
24. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ; Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001; Aug 30;345(9):638–46.
25. van Gijn W, Marijnen CA, Nagtegaal ID, Kranenbarg EM, Putter H, Wiggers T, Rutten HJ, Påhlman L, Glimelius B, van de Velde CJ; Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 2011; Jun;12(6):575–82.
26. Mirnezami AH, Sagar PM, Kavanagh D, Witherspoon P, Lee P, Winter D. Clinical algorithms for the surgical management of locally recurrent rectal cancer. Dis Colon Rectum. 2010; Sep;53(9):1248–57.
27. Reerink O, Mulder NH, Botke G, Sluiter WJ, Szabó BG, Plukker JT, Verschueren RC, Hospers GA. Treatment of locally recurrent rectal cancer, results and prognostic factors. Eur J Surg Oncol. 2004; Nov;30(9):954–8.
28. Miller AR. Multidisciplinary management of recurrent colorectal cancer. Surg Oncol. 1998; Nov-Dec;7(3–4):209–21.
29. Harji DP, Griffiths B, McArthur DR, Sagar PM. Surgery for recurrent rectal cancer: higher and wider? Colorectal Dis. 2013; Feb;15(2):139–45.
30. Hyngstrom JR, Tzeng CW, Beddar S, Das P, Krishnan S, Delclos ME, Crane CH, Chang GJ, You YN, Feig BW, Skibber JM, Rodriguez-Bigas MA. Intraoperative radiation therapy for locally advanced primary and recurrent colorectal cancer: Ten-year institutional experience. J Surg Oncol. 2014; Jun;109(7):652–8.
31. Asoglu O, Karanlik H, Muslumanoglu M, Igci A, Emek E, Ozmen V, Kecer M, Parlak M, Kapran Y. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience. Eur J Surg Oncol. 2007; Dec;33(10):1199–206.
32. Harji DP, Sagar PM, Boyle K, Griffiths B, McArthur DR, Evans M. Surgical resection of recurrent colonic cancer. Br J Surg. 2013; Jun;100(7):950–8.